Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
521.00
0.00 (0.00%)
At close: Jun 27, 2025, 4:00 PM
524.00
+3.00 (0.58%)
After-hours: Jun 27, 2025, 7:50 PM EDT
Regeneron Pharmaceuticals Analyst Ratings
Total Analysts
22
Consensus Rating
Buy
Price Target
$839.91
Upside
+61.21%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $950 → $800 | Buy | Maintains | $950 → $800 | +53.55% | Jun 9, 2025 |
| UBS | UBS | Hold Maintains $633 → $560 | Hold | Maintains | $633 → $560 | +7.49% | Jun 5, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $700 → $650 | Strong Buy | Maintains | $700 → $650 | +24.76% | Jun 2, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $800 → $600 | Buy | Maintains | $800 → $600 | +15.16% | Jun 2, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $958 → $755 | Buy | Maintains | $958 → $755 | +44.91% | Jun 2, 2025 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $700 → $580 | Buy → Hold | Downgrades | $700 → $580 | +11.32% | May 30, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $943 | Buy | Reiterates | $943 | +81.00% | May 27, 2025 |
| Citigroup | Citigroup | Hold → Strong Buy Upgrades $600 → $700 | Hold → Strong Buy | Upgrades | $600 → $700 | +34.36% | May 14, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $940 → $810 | Strong Buy | Maintains | $940 → $810 | +55.47% | May 1, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $975 → $940 | Strong Buy | Maintains | $975 → $940 | +80.42% | Apr 30, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $917 → $804 | Strong Buy | Maintains | $917 → $804 | +54.32% | Apr 30, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $1,051 → $943 | Buy | Maintains | $1,051 → $943 | +81.00% | Apr 30, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $750 → $700 | Buy | Maintains | $750 → $700 | +34.36% | Apr 30, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $865 → $800 | Buy | Maintains | $865 → $800 | +53.55% | Apr 30, 2025 |
| UBS | UBS | Hold Maintains $768 → $633 | Hold | Maintains | $768 → $633 | +21.50% | Apr 30, 2025 |
| Baird | Baird | Hold Maintains $652 → $587 | Hold | Maintains | $652 → $587 | +12.67% | Apr 30, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.